Article Text

PDF
AB0087 Sonic hedgehog promotes fibroblast-like synoviocytes proliferation via modulating the mapk/erk signaling pathway in rheumatoid arthritis
  1. F Liu1,
  2. S-L Zhu2,
  3. Y-F Pan1,
  4. J-L Huang2
  1. 1Rheumatology, the Third Affiliated Hospital of Sun Yat-Sen University
  2. 2Rheumatology, the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Abstract

Background The Sonic hedgehog (Shh) signaling has been reported to be activated in synovium of RA patients and RA-FLS in vitro [1]. Further, Shh signaling plays an important role in RA-FLS proliferation [2]. As for the extracellular signal-regulated kinase (ERK),is a member of mitogen-activated protein kinase (MAPK) [3], which has been reported to be involved in proliferation of RA-FLS [4]. However, the role of MAPK/ERK signaling pathway in the proliferation of RA-FLS modulating by Shh is unclear.

Objectives To study the effect of MAPK/ERK signaling pathway on cell proliferation modulated by Sonic hedgehog (Shh) signaling in fibroblast-like synoviocytes isolated from patients with active rheumatoid arthritis (RA-FLS).

Methods The RA-FLS were primarily cultured by the explant culture, and then were treated with Shh agonist Purmorphamine,inhibitor Cyclopamine or MAPK/ERK signaling pathway inhibitor U0126, respectively. Western blots was used to examine the phosphorylation level of ERK 1/2 (p-ERK1/2), which was the critical protein of MAPK/ERK signaling. The cell proliferation activity was detected using cell proliferation and cytotoxicity kit-8 (CCK8),and the cell proliferation rate was detected using a flow cytometry.

Results Compared with the control group, Purmorphamine transiently increased p-ERK1/2 protein at the concentration of 1 μM, and the peak activations of p-ERK1/2 took place at 15min (P<0.01). Cyclopamine and U0126 decreased the expression of p-ERK1/2 protein (P<0.01). After the RA-FLS treated with Purmorphmine (1μM) for 48 hours, the cell proliferation activity was 114±4% and the percentage of S phase cells was 8.39±0.60%, significantly higher than those of the control group 100±0% (P<0.01) and 3.29±0.69% (P<0.01). After treated with Cyclopamine (10μM) for 48 hours, the cell proliferation activity of RA-FLS was 89±1% (P<0.05) and the percentage of S phase cells was 1.53±0.22% (P<0.05). When co-treated with purmorphamine (1μM) and U0126 (10μM), the cells proliferative activity was 892% (P<0.05) and the percentage of S phase cells was 1.07±0.25% (P<0.05).

Conclusions Shh might promote proliferaton of RA-FLS via modulating MAPK/ERK signaling, subsequently contributing to hyperlasia of synovium and ultimately leading to RA disease.

References

  1. Wang M, et al. Sonic hedgehog signaling drives proliferation of synoviocytes in rheumatoid arthritis: a possible novel therapeutic target[J]. J Immunol Res, 2014, 2014: 401903.

  2. Zhu SL, et al. Inhibition of smoothened decreases proliferation of synoviocytes in rheumatoid arthritis[J]. Cell Mol Immunol, 2015. DOI: 10.1038/cmi.2015.67.

  3. Elia D, et al. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: Involvement of MAPK/ERK and PI3K/Akt pathways[J]. Biochim Biophys Acta, 2007. 1773(9): 1438–46.

  4. Morel J, Audo R, Hahne M, Cet al. umor necrosis factor related apoptosis inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen activated protein kinases and phosphatidylinositol3-kinase/Akt[J]. J Biol Chem 2005. 280(16):15709–15718.

References

Acknowledgements This study was supported by the National Natural Science Foundation of China (No.81571584). I thank Jianlin Huang for protocols.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.